BRCACRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。BRCA遺伝子サイレンサーは、BRCA CRISPR/Cas9ノックアウトプラスミドとBRCADouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のBRCACRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
BRCA CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
BRAT1 CRISPR/Cas9 KOプラスミド (h) | sc-415146 | h | Gene Knockout | GFP | 0 | ||
BRAT1 HDRプラスミド (h) | sc-415146-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
BRAT1 Double Nickaseプラスミド (h) | sc-415146-NIC | h | Gene Knockout | Puromycin | 0 | ||
BRAT1 Double Nickaseプラスミド (h2) | sc-415146-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
BRAT1 CRISPR/Cas9 KOプラスミド (m) | sc-433111 | m | Gene Knockout | GFP | 0 | ||
BRAT1 HDRプラスミド (m) | sc-433111-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
BRAT1 Double Nickaseプラスミド (m) | sc-433111-NIC | m | Gene Knockout | Puromycin | 0 | ||
BRAT1 Double Nickaseプラスミド (m2) | sc-433111-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
BRCA1 CRISPR/Cas9 KOプラスミド (h) | sc-400093 | h | Gene Knockout | GFP | 0 | ||
BRCA1 HDRプラスミド (h) | sc-400093-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
BRCA1 Double Nickaseプラスミド (h) | sc-400093-NIC | h | Gene Knockout | Puromycin | 0 | ||
BRCA1 Double Nickaseプラスミド (h2) | sc-400093-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
BRCA1 CRISPR/Cas9 KOプラスミド (m) | sc-419362 | m | Gene Knockout | GFP | 2 | ||
BRCA1 HDRプラスミド (m) | sc-419362-HDR | m | Homology Directed Repair | Puromycin | 2 | ||
BRCA1 Double Nickaseプラスミド (m) | sc-419362-NIC | m | Gene Knockout | Puromycin | 2 | ||
BRCA1 Double Nickaseプラスミド (m2) | sc-419362-NIC-2 | m | Gene Knockout | Puromycin | 2 | ||
BRCA1 CRISPR/Cas9 KOプラスミド (r) | sc-437320 | r | Gene Knockout | GFP | 0 | ||
BRCA1 HDRプラスミド (r) | sc-437320-HDR | r | Homology Directed Repair | Puromycin | 0 | ||
BRCA1 Double Nickaseプラスミド (r) | sc-437320-NIC | r | Gene Knockout | Puromycin | 0 | ||
BRCA1 Double Nickaseプラスミド (r2) | sc-437320-NIC-2 | r | Gene Knockout | Puromycin | 0 | ||
BRCA2 CRISPR/Cas9 KOプラスミド (h) | sc-400700 | h | Gene Knockout | GFP | 4 | ||
BRCA2 HDRプラスミド (h) | sc-400700-HDR | h | Homology Directed Repair | Puromycin | 4 | ||
BRCA2 Double Nickaseプラスミド (h) | sc-400700-NIC | h | Gene Knockout | Puromycin | 4 | ||
BRCA2 Double Nickaseプラスミド (h2) | sc-400700-NIC-2 | h | Gene Knockout | Puromycin | 4 | ||
BRCA2 CRISPR/Cas9 KOプラスミド (m) | sc-419363 | m | Gene Knockout | GFP | 0 | ||
BRCA2 HDRプラスミド (m) | sc-419363-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
BRCA2 Double Nickaseプラスミド (m) | sc-419363-NIC | m | Gene Knockout | Puromycin | 0 | ||
BRCA2 Double Nickaseプラスミド (m2) | sc-419363-NIC-2 | m | Gene Knockout | Puromycin | 0 |
BRCA CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
BRAT1 CRISPR Activationプラスミド (h) | sc-415146-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRAT1 CRISPR Activationプラスミド (h2) | sc-415146-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRAT1 Lentiviral Activation Particles (h) | sc-415146-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRAT1 Lentiviral Activation Particles (h2) | sc-415146-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRAT1 CRISPR Activationプラスミド (m) | sc-433111-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRAT1 CRISPR Activationプラスミド (m2) | sc-433111-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRAT1 Lentiviral Activation Particles (m) | sc-433111-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRAT1 Lentiviral Activation Particles (m2) | sc-433111-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRCA1 CRISPR Activationプラスミド (h) | sc-400093-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRCA1 CRISPR Activationプラスミド (h2) | sc-400093-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRCA1 Lentiviral Activation Particles (h) | sc-400093-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRCA1 Lentiviral Activation Particles (h2) | sc-400093-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRCA1 CRISPR Activationプラスミド (m) | sc-419362-ACT | m | Gene Activation | Puro, Blast, Hygro | 2 | ||
BRCA1 CRISPR Activationプラスミド (m2) | sc-419362-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 2 | ||
BRCA1 Lentiviral Activation Particles (m) | sc-419362-LAC | m | Gene Activation | Puro, Blast, Hygro | 2 | ||
BRCA1 Lentiviral Activation Particles (m2) | sc-419362-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 2 | ||
BRCA1 CRISPR Activationプラスミド (r) | sc-437320-ACT | r | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRCA1 CRISPR Activationプラスミド (r2) | sc-437320-ACT-2 | r | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRCA1 Lentiviral Activation Particles (r) | sc-437320-LAC | r | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRCA1 Lentiviral Activation Particles (r2) | sc-437320-LAC-2 | r | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRCA2 CRISPR Activationプラスミド (h) | sc-400700-ACT | h | Gene Activation | Puro, Blast, Hygro | 4 | ||
BRCA2 CRISPR Activationプラスミド (h2) | sc-400700-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 4 | ||
BRCA2 Lentiviral Activation Particles (h) | sc-400700-LAC | h | Gene Activation | Puro, Blast, Hygro | 4 | ||
BRCA2 Lentiviral Activation Particles (h2) | sc-400700-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 4 | ||
BRCA2 CRISPR Activationプラスミド (m) | sc-419363-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRCA2 CRISPR Activationプラスミド (m2) | sc-419363-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRCA2 Lentiviral Activation Particles (m) | sc-419363-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BRCA2 Lentiviral Activation Particles (m2) | sc-419363-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |